Ana Villar

Dr. Ana Villar

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
FMFerran Morell
Ferran Morell
AVAna Villar
Ana Villar
MMMaría-Ángeles Montero
María-Ángeles Montero
XMXavier Muñoz
Xavier Muñoz
TCThomas V Colby
Thomas V Colby
GRGanesh Raghu
Ganesh Raghu

4 December 2018 in Allergy
Verified
Journal Article
Closed access
PDF file
IOIñigo Ojanguren
Iñigo Ojanguren
FMFerran Morell
Ferran Morell
MRMaria A Ramon
Maria A Ramon
AVAna Villar
Ana Villar
CRChristian Romero
Christian Romero
XMXavier Muñoz
Xavier Muñoz

19 August 2014 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
XMXavier Muñoz
Xavier Muñoz
MSMónica Sánchez-Ortiz
Mónica Sánchez-Ortiz
FTFerran Torres
Ferran Torres
AVAna Villar
Ana Villar
FMFerran Morell
Ferran Morell
María-Jesús CruzMaría-Jesús Cruz
María-Jesús Cruz
Reliable methods are needed to diagnose hypersensitivity pneumonitis. The aim of the study was to establish the diagnostic yield of specific inhalation challenge (SIC) in patients with hypersensitivity pneumonitis.All patients with suspected hypersensitivity pneumonitis in whom SIC was performed (n=113) were included. SIC was considered positive when patients showed a decrease of >15% in forced vital capacity (FVC) or >20% in diffusing capacity of the lung for carbon dioxide, or a decrease of 10% to 15% in FVC accompanied by a temperature increase of 0.5°C within 24 h of inhalation of the antigen.SIC was positive to the agents tested in 68 patients: 64 received a diagnosis of hypersensitivity pneumonitis and SIC results were considered false-positive in the remaining four patients. In the SIC-negative group (n=45), 24 patients received a diagnosis of hypersensitivity pneumonitis and SIC results were considered false-negative, and 21 patients were diagnosed with other respiratory diseases. The sensitivity and specificity of the test were 72.7% and 84%, respectively. Having hypersensitivity pneumonitis caused by an antigen other than birds or fungi predicted a false-negative result (p=0.001).In hypersensitivity pneumonitis, positive SIC testing virtually confirms the diagnosis, whereas negative testing does not rule it out, especially when the antigenic sources are not birds or fungi.

1 January 2015 in Medicine
Verified
Journal Article
Open access
Fernando SalvadorFernando Salvador
Fernando Salvador
ILIbai Los-Arcos
Ibai Los-Arcos
ASAdrián Sánchez-Montalvá
Adrián Sánchez-Montalvá
MTMaría Teresa Tórtola
María Teresa Tórtola
ACAdria Curran
Adria Curran
Israel MolinaIsrael Molina
Israel Molina
The aim of this article is to describe epidemiological and clinical data of patients with tuberculous lymphadenitis (TL) and evaluate the yield of the diagnostic techniques employed. Retrospective observational study was performed at the Vall d’Hebron University Hospital, Barcelona, Spain. All adult patients with confirmed TL (microbiologically) or probable TL (suspected by clinical presentation, cyto/histopathological features, and clinical improvement after specific treatment) diagnosed from January 2001 to December 2013 were included. One hundred twenty-two patients were included: 78 (63.9%) patients with confirmed diagnosis and 44 (36.1%) patients with probable TL. Seventy (57.4%) patients were nonnative residents. From 83 fine-needle aspiration (FNA) specimens, 54.8% (40/73) showed granulomatous inflammation, 62.5% (40/64) had positive mycobacterial culture, and 73.3% (11/15) tested positive with Xpert MTB/RIF (Cepheid, Sunnyvale, CA). From 62 biopsy samples, 96.8% (60/62) showed granulomatous inflammation, 64.6% (31/48) had positive mycobacterial culture, and 46.1% (6/13) tested positive with Xpert MTB/RIF. TL has increasingly been diagnosed in our setting, mostly because of cases diagnosed in nonnative residents. FNA is an easy and safe technique for the diagnosis of suspected TL, and the yield regarding mycobacterial culture seems to be similar to the obtained with biopsy. The Xpert MTB/RIF test from FNA specimens may increase the accuracy of the TL diagnosis and provides quicker results.

27 May 2016 in Seminars in Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
PDF file
AVAna Villar
Ana Villar
IOIñigo Ojanguren
Iñigo Ojanguren
XMXavier Muñoz
Xavier Muñoz
María-Jesús CruzMaría-Jesús Cruz
María-Jesús Cruz
FMFerran Morell
Ferran Morell
This review presents an update of the currently available information related to hypersensitivity pneumonitis, with a particular focus on the contribution of several techniques in the diagnosis of this condition. The methods discussed include proper elaboration of a complete medical history, targeted auscultation, detection of specific immunoglobulin G antibodies against the most common antigens causing this disease, skin tests, antigen-specific lymphocyte activation assays, bronchoalveolar lavage, and cryobiopsy. Special emphasis is placed on the relevant contribution of specific inhalation challenge (bronchial challenge test). Surgical lung biopsy is presented as the ultimate recourse, to be used when the diagnosis cannot be reached through the other methods covered.

27 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAdrian-Sanchez Montalva
Adrian-Sanchez Montalva
MBMarta Barios
Marta Barios
Fernando SalvadorFernando Salvador
Fernando Salvador
AVAna Villar
Ana Villar
MTMaría Teresa Tórtola
María Teresa Tórtola
IMIsrael Molina
Israel Molina
The aim of our study is to describe the FDG-PET/CT findings in patients with tuberculosis and to correlate them with the patient’s prognosis. We retrospectively collected data from patients with tuberculosis, who had an FDG-PET/CT performed prior to treatment initiation from 2010 to 2015. Forty-seven out of 504 patients with active tuberculosis diagnosis (9.33%) underwent an FDG-PET/CT. The reasons for performing the FDG-PET/CT were: characterization of a pulmonary nodule (24; 51.1%), study of fever of unknown origin (12; 25.5%), study of lymph node enlargement (5; 10.6%) and others (6; 12.8%). Median age was 64 (IQR 50–74) years and 31 (66%) patients were male. Twenty-six (55.3%) patients had an immunosuppressant condition. According to the FDG-PET/CT, 48.6% of the patients had more than 1 organ affected and 46.8% had lymph node involvement. Median SUVmax of the main lesion was 5 (IQR 0.28–11.85). We found an association between the FDG accumulation and the size of the main lesion with a correlation coefficient of 0.54 (p<0.002). Patients with an unsuccessful outcome had a higher ratio SUVmax main lesion / SUVmean liver (1.92 vs 7.67, p<0.02). In our cohort, almost half of the patients had more than 1 organ affected and 46.8% of them had lymph node involvement. FDG uptake was associated with the size of the main lesion and seems to be related to the treatment outcome. The extent of its potential to be used as an early predictor of treatment success still needs to be defined.